Drug Profile
Research programme: TGF-beta antagonists - GLYCODesign
Alternative Names: TGF-beta antagonists research programme - GLYCODesign; Transforming growth factor-beta antagonists research programme - GLYCODesignLatest Information Update: 20 Aug 2002
Price :
$50
*
At a glance
- Originator GLYCODesign; Nonindustrial source
- Class
- Mechanism of Action Transforming growth factor beta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Inflammation; Viral infections
Most Recent Events
- 20 Aug 2002 Discontinued - Preclinical for Cancer in Canada (unspecified route)
- 20 Aug 2002 Discontinued - Preclinical for Inflammation in Canada (unspecified route)
- 20 Aug 2002 Discontinued - Preclinical for Viral infections in Canada (unspecified route)